(Q38001495)

26 August 2017

title

Detection of anti-HLA antibodies by solid-phase assay in kidney transplantation: friend or foe? (English)

1 reference

26 August 2017

S Ferrari-Lacraz

1

1 reference

26 August 2017

J-M Tiercy

series ordinal

2

1 reference

26 August 2017

J Villard

series ordinal

3

1 reference

26 August 2017

publication date

1 May 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

79

1 reference

26 August 2017

issue

5

1 reference

26 August 2017

page(s)

315-325

1 reference

ABO-incompatible kidney transplantation: current practice and the decade ahead

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

ABO incompatible renal transplantation: a paradigm ready for broad implementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Humoral theory of transplantation: further evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Effect of antibodies on endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Endothelial cells in allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Normal human kidney HLA-DR-expressing renal microvascular endothelial cells: characterization, isolation, and regulation of MHC class II expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Banff 07 classification of renal allograft pathology: updates and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Back to the future: application of contemporary technology to long-standing questions about the clinical relevance of human leukocyte antigen-specific alloantibodies in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Significance of the positive crossmatch test in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Sensitization and sensitivity: defining the unsensitized patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Luminex donor-specific crossmatches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Donor-specific antibody levels and three generations of crossmatches to predict antibody-mediated rejection in kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Clinical relevance of circulating donor-specific HLA antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Antiallograft antibodies: relevance, detection, and monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Humoral theory of transplantation: mechanism, prevention, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Antibody-reactive epitope determination with HLAMatchmaker and its clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Correlations between Terasaki's HLA class II epitopes and HLAMatchmaker-defined eplets on HLA-DR and -DQ antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Epitopes of human leukocyte antigen class I antibodies found in sera of normal healthy males and cord blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Using real data for a virtual crossmatch

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Sensitization after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Predictive value of HLA antibodies and serum creatinine in chronic rejection: results of a 2-year prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Clinical relevance of anti-HLA antibodies detected by flow-cytometry bead-based assays--single-center experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Calculated PRA (CPRA): the new measure of sensitization for transplant candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Transplanting the highly sensitized patient: The emory algorithm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Human leukocyte antigen antibody detection and kidney allocation within Eurotransplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Presensitization: the problem and its management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Rituximab and intravenous immune globulin for desensitization during renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

A single low-fixed dose of rituximab to salvage renal transplants from refractory antibody-mediated rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Sensitized renal transplant recipients: current protocols and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Combined posttransplant prophylactic IVIg/anti-CD 20/plasmapheresis in kidney recipients with preformed donor-specific antibodies: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

The spectrum of antibody-mediated renal allograft injury: implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

Microdroplet Assay of Human Serum Cytotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2012.01853.X

10.1111/J.1399-0039.2012.01853.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference